+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Implants Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

  • PDF Icon

    Report

  • 185 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5748942

Tehcnolgoy such as mRNA, VR, Neurotechnology are paving lucrative opportunities for the applications of Medical Implants

The Global Medical Implants Market is estimated to be USD 94.52 Bn in 2023 and is expected to reach USD 140.3 Bn by 2028 growing at a CAGR of 8.22%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Medical Implants Market is segmented based on Product, Type of Material, and Geography.
  • By Product, the market is classified into Orthopedic Implants, Cardiovascular Implants, Stents, Stent-Related Implants, Structural Cardiac Implants, Spinal Implants, Neurostimulators, Ophthalmic Implants, Dental Implants, Facial Implants, and Breast Implants.
  • By Type of Material, the market is classified into Metallic Biomaterial, Polymers Biomaterial, Natural Biomaterial, and Ceramic Biomaterial.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3M Co., Abbott Laboratories, Boston Scientific Corp., Cardinal Health, Inc., Johnson & Johnson Services, Inc., Smith & Nephew PLC, Straumann Ag, Stryker Corp., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Medical Implants Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Medical Implants Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Medical Implants Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Prevalences of Organ Failures
4.1.2 Increasing Demand for Cosmetic Dentistry
4.1.3 Increase in the Development of Minimally Invasive
4.1.4 Global Rise in Acceptance of Medical Implants
4.1.5 Increasing Cases of Road Accidents and Sports Injuries
4.2 Restraints
4.2.1 Stringent Approval Process
4.2.2 Costly Procedure of Artificial Implantation
4.3 Opportunities
4.3.1 Insufficient Organ Donors
4.3.2 Rising Number of FDA Approvals
4.3.3 Technological Advancements in the Medical Implants
4.4 Challenges
4.4.1 Uncertain Reimbursement Policies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Medical Implants Market, By Product
6.1 Introduction
6.2 Orthopaedic Implants
6.2.1 Reconstructive Joint Replacements
6.2.1.1 Knee Replacement Implants
6.2.1.2 Hip Replacement Implants
6.2.1.3 Extremities
6.2.2 Orthobiologics
6.2.3 Trauma & Craniomaxillofacial
6.3 Cardiovascular Implants
6.3.1 Pacing Devices
6.3.1.1 Cardiac Resynchronization Therapy Devices (CRTs)
6.3.2 Implantable Cardioverter Defibrillators (ICDs)
6.3.2.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
6.3.2.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
6.3.3 3. Implantable Cardiac Pacemakers (ICPs)
6.4 Stents
6.4.1 Coronary Stents
6.4.1.1 Drug-Eluting Stents (DES)
6.4.1.2 Bare-Metal Coronary Stents
6.4.1.3 Bioabsorbable Stents
6.4.2 Peripheral Stents
6.4.3 Iliac
6.4.4 Femoral-Popliteal
6.4.5 Renal
6.4.6 Carotid
6.5 Stent-Related Implants
6.5.1 Synthetic Grafts
6.5.2 Vena Cava Filters
6.6 Structural Cardiac Implants
6.6.1 Mechanical Heart Valves
6.6.2 Implantable Ventricular-assist Devices
6.7 Spinal Implants
6.7.1 Spinal Fusion Implants
6.7.2 Spinal Bone Stimulators
6.7.3 Vertebral Compression Fracture (VCF) Devices
6.7.4 Motion Preservation Devices/Non-fusion Devices
6.8 Neurostimulators
6.8.1 Deep Brain Stimulation (DBS)
6.8.2 Sacral Nerve Stimulation (SNS)
6.8.3 Vagus Nerve Stimulation (VNS)
6.8.4 Spinal Cord Stimulation (SCS)
6.9 Ophthalmic Implants
6.9.1 Intraocular Lens
6.9.2 Glaucoma Implants
6.10 Dental Implants
6.10.1 Plate Form Dental Implants
6.10.2 Root Form Dental Implants
6.11 Facial Implants
6.12 Breast Implants
7 Global Medical Implants Market, By Type of Material
7.1 Introduction
7.2 Metallic Biomaterial
7.3 Polymers Biomaterial
7.4 Natural Biomaterial
7.5 Ceramic Biomaterial
8 Americas' Medical Implants Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Medical Implants Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Medical Implants Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Medical Implants Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 3M Co.
13.2 Abbott Laboratories
13.3 Abbvie Inc. (Allergan PLC)
13.4 Biotronik SE & Co. KG
13.5 Boston Scientific Corp.
13.6 Cardinal Health, Inc.
13.7 ConMed Corp.
13.8 Dentsply Sirona
13.9 GC Aesthetics France SAS
13.10 Globus Medical, Inc.
13.11 Henry Schein Inc.
13.12 Institut Straumann Ag
13.13 Integra Lifesciences Holdings Corp.
13.14 Ivoclar Vivadent Inc.
13.15 Johnson & Johnson Services, Inc.
13.16 LivaNova PLC
13.17 Medtronic PLC
13.18 NuVasive, Inc.
13.19 Osstem Implant Co. Ltd.
13.20 Smith & Nephew PLC
13.21 Straumann Ag
13.22 Stryker Corp.
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • 3M Co.
  • Abbott Laboratories
  • Abbvie Inc. (Allergan PLC)
  • Biotronik SE & Co. KG
  • Boston Scientific Corp.
  • Cardinal Health, Inc.
  • ConMed Corp.
  • Dentsply Sirona
  • GC Aesthetics France SAS
  • Globus Medical, Inc.
  • Henry Schein Inc.
  • Institut Straumann Ag
  • Integra Lifesciences Holdings Corp.
  • Ivoclar Vivadent Inc.
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • NuVasive, Inc.
  • Osstem Implant Co. Ltd.
  • Smith & Nephew PLC
  • Straumann Ag
  • Stryker Corp.